ODI Pharma AB (publ) (NGM:ODI)
Sweden
· Delayed Price · Currency is SEK 1.700
-0.460 (-21.30%)
At close: Jun 11, 2025
ODI Pharma AB Revenue
ODI Pharma AB had revenue of 2.93M SEK in the quarter ending March 31, 2025, a decrease of -78.82%. This brings the company's revenue in the last twelve months to 10.57M, down -28.58% year-over-year. In the fiscal year ending June 30, 2024, ODI Pharma AB had annual revenue of 22.29M with 15,880.34% growth.
Revenue (ttm)
10.57M
Revenue Growth
-28.58%
P/S Ratio
3.01
Revenue / Employee
10.57M
Employees
1
Market Cap
31.83M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Investor AB | 104.49B |
| Atlas Copco AB | 176.63B |
| AB Volvo | 517.43B |
| Skandinaviska Enskilda Banken AB | 79.55B |
| ASSA ABLOY AB | 152.90B |
| EQT AB | 30.39B |
| Swedbank AB | 73.90B |
| Telefonaktiebolaget LM Ericsson | 249.58B |